+462.0%
MRNA vs RY
+44.8%
+417.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -0.4% | +1.1% | +0.4% |
| 7D | -8.2% | -2.9% | -5.4% | -10.4% |
| 30D | +125.6% | -2.0% | +127.6% | +117.9% |
| 3M | +197.1% | +4.9% | +192.2% | +166.6% |
| 6M | +148.5% | +26.1% | +122.4% | +81.3% |
| YTD | +363.3% | +22.4% | +340.9% | +246.0% |
| 1Y | +462.0% | +44.7% | +417.2% | +195.7% |
| All | +462.0% | +44.8% | +417.2% | +195.7% |
Cumulative growth
Daily Returns
Daily percentage return beside RY.
Daily Out/Under-Performance
Portfolio return minus RY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling